The University of Chicago Header Logo

Connection

John Moroney to Piperazines

Back to Details
This is a "connection" page, showing publications John Moroney has written about Piperazines.
John Moroney
Connection Strength
0.209
Piperazines
  1. NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer. 2024 Apr 15; 130(8):1234-1245.
    View in: PubMed
    Score: 0.209
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.